Statins

Description: The purpose of this guideline is to assist in making decisions about first-line, second-line or third-line management of patients at elevated risk of coronary heart disease using statins

Publet Introduction:

This publet relates only to the initiation of statin therapy in adults with clinical evidence of cardiovascular disease (CVD) and in adults considered to be at risk of CVD. It assumes that other strategies for managing CVD risk are being appropriately considered when initiating statin therapy. The guidance does not include specific advice for genetic dyslipidaemias (for example, familial hypercholesterolaemia). The guidance relates only to the use of statins within their licensed indications.

The publet was developed some years ago from an early version of the guideline: it has not been significantly updated since the original implementation and should not be used for any advisory or clinical purpose.

 
 Information
Guideline Objectives

The purpose of this guideline is to assist in making decisions about first-line, second-line or third-line management of patients at elevated risk of coronary heart disease using statins

Target SettingPrimary care
Target Users
  • Author
  • Release Date 14/05/2013
Overview
Provenance7.No provenance has been assigned (default value)
Management

The purpose of this guideline is to assist in making decisions about first-line, second-line or third-line management of patients at elevated risk of coronary heart disease using statins

Safety CaseNone developed
Sources

Original documentation not available

See NICE Technology Appraisal 94 “Statins for the prevention of cardiovascular events Ordering information” You can download the following documents from www.nice.org.uk/TA094

References